Trainline Raises FullYear Guidance for Second Time in 2026
ABC Files Early Station License Renewals Questions Legitimacy of Process
EOG Resources Surges in Q1 as Oil Prices and Operational Strength Drive Investor Optimism
US Productivity Growth Slows in Q4 as Unit Labor Costs Accelerate
Tencent Focuses on AI Agents and Smaller Models in Competitive Landscape Against Alibaba and ByteDance
White House Announces New Soybean and Rare Earths Agreements Following TrumpXi Summit China Signals Tariff Reduction
HIMX Q1 2026 Earnings Slight EPS Beat Drives Positive Market Reaction
Brookfield Corporation BN Q1 2026 Earnings EPS Beats Estimates Amidst Modest Stock Pullback
HUT Q3 2024 Earnings EPS Surprises to the Upside as Costs Tighten
AAP Q1 2026 Earnings Significant EPS Beat Amid Mixed Operational Trends
KKRT Q1 2026 Earnings EPS Surpasses Expectations Amid Strong Investment Performance
Gran Tierra Energy Inc Q4 2025 Earnings Net Loss Reported as Oil Producer Navigates Lower Prices
Calamos Global Total Return Fund CGO Edges Higher Holding Near Resistance
DT Cloud Star Acquisition Corporation DTSQ Holds Steady Near 1122 Amid Quiet Trading
Quad Graphics Inc QUAD Edges Higher as Stock Tests Key Resistance Zone
Emerson Radio MSN Slides 284 as Stock Tests Key Support at 042
Pimco New York Municipal Income Fund II PNI Edges Higher as YieldSeeking Investors Return
Eli Lilly Expands Vaccine Portfolio with Up to 38 Billion in Deals for Three Developers
OnKure Therapeutics OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline
FIGS Inc Edges Higher as Stock Approaches Resistance Zone
Lam Research LRCX Receives Analyst Upgrades Amid Oversold Growth Stock Interest
Nvidias PostEarnings Dip The Broader Context Sellers May Be Overlooking
Custard Apple Exports Face Challenges Despite Hardy Plant Characteristics
Quantinuum Files for IPO Quantum Computing Startup Targets 13 Billion Valuation
Lowenstein Sandler Hires Scott D Fisher to Strengthen MA and Capital Markets Practice
Spotify Jumps 13 After AI Music Deal with Universal Music and 2030 Revenue Guidance
Arrowhead Pharmaceuticals Presents Plozasiran Data on Renal and Hepatic Impairment